Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin-Reference-Cited by-同舟云学术

Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin

Author:

Wang Jun¹,Gou Yi¹²,Zhang Zhenlei¹,Yu Ping¹,Qi Jinxu¹,Qin Qipin¹,Sun Hongbin¹,Wu Xiaoyang³,Liang Hong¹,Yang Feng¹^ORCID

Affiliation:

1. State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin, Guangxi 541003, China

2. School of Pharmacy, Nantong University, Nantong, Jiangsu 226000, China

3. Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois 60637, United States

Funder

Ministry of Education of the People's Republic of China

Natural Science Foundation of Guangxi Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

Reference84 articles.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献